Aurinia Pharmaceuticals (IKAP.MU) Q1 2026 Earnings

26FebConfirmed
Q1 2026
0.18
0.55
0.93
1.3

Details

Expected EPS
0.18358628244
Actual EPS
1.2963996
Surprise EPS
1.11
Surprise Percent
+606.15%

Description

Aurinia Pharmaceuticals (IKAP.MU) has reported earnings of 1.2963996 per share for Q1 2026.

0 Comments

Share your thoughts